/PRNewswire/ Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2023 results. "We were very pleased with the overall execution on.
Perrigo Reports First Quarter 2021 Financial Results From Continuing Operations
Consumer Transformation Nearing Completion Ahead of Schedule
Rx Transaction On-Track to Close in Q3 21; Rx Segment Now Reported in Discontinued Operations
2021 Guidance Reaffirmed
Share this article
Share this article
DUBLIN, May 11, 2021 /PRNewswire/ Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Consumer Self-Care Products, today announced financial results from continuing operations for the first quarter of fiscal year 2021 ended April 3, 2021. The Consumer Self-Care Americas ( CSCA ) segment, the Consumer Self-Care International ( CSCI ) segment and Corporate are included in results from continuing operations. Financial results from the generic Rx pharmaceuticals business are reported as discontinued operations. All comparisons are against the prior-year fiscal first quarter, unless otherwise noted.